Volume 15, Number 6—June 2009
Recurrent Human Rhinovirus Infections in Infants with Refractory Wheezing
To the Editor: Respiratory infections frequently cause illness among pediatric patients worldwide. Human rhinovirus (HRV) is a cause of acute respiratory tract infections (RTIs) (1); co-infections with other respiratory viruses such as respiratory syncytial virus (RSV) or influenza virus have also been reported. HRV strains have been subdivided into 2 genetic subgroups (HRV-A and HRV-B); a third genetic subgroup has been recently discovered (2–7). However, understanding of the epidemiology of novel HRV infection among Asian pediatric patients with respiratory illness (4,5) and association with recurrent wheezing and asthma has been limited (8–10).
We retrospectively analyzed 289 nasopharyngeal aspirates (NPAs) obtained from 286 pediatric patients admitted to Chulalongkorn Memorial Hospital in Bangkok, Thailand, during 2006–2007. The study was reviewed and approved by the Institutional Review Board, Chulalongkorn University, Bangkok, Thailand. Each specimen was tested for common respiratory viruses such as RSV, HRV, parainfluenza 1–3, influenza A and B viruses, adenovirus, human metapneumovirus, and human bocavirus. On the basis of phylogenetic analysis of the VP4 region, we identified 2 patients who had been admitted with 5 episodes of acute RTIs and subsequent recurrent wheezing associated with HRV-A and HRV-C.
The first patient was an infant girl whose first episode of breathing difficulty was at 5 months of age; a diagnosis of RSV bronchiolitis was made. She was hospitalized with respiratory failure and required mechanical ventilation for 3 days. At 6 months, she had pneumonia and wheezing. At 14 months, she had a low-grade fever, mild cough, breathing difficulty, and wheezing. While she was hospitalized for 7 days, a novel HRV-C (FJ435240) was identified by seminested PCR, and RSV was detected by reverse transcription–PCR. Seven months later, she had recurrent wheezing and respiratory distress. Virologic analysis indicated that she was co-infected with a divergent HRV-C strain (FJ435256) and influenza A virus. Nucleotide sequence identity score between the 2 isolated strains of HRV-C indicated a different cluster (identity score 70.1%).
The second patient was an infant boy with a diagnosis of acute bronchiolitis at 7 months of age. His underlying condition was congenital heart disease and an allergy to cow’s milk protein. Initial NPA showed HRV-A (FJ435274) and RSV by reverse transcription–PCR. Two months later, he had viral pneumonia and acute exacerbation of his reactive airway disease. He received systemic corticosteroids and a nebulized bronchodilator. His clinical course was complicated by 3 episodes of supraventricular tachycardia that were controlled with adenosine and cordarone. NPA was again positive for HRV-A (FJ435284). Three weeks later, he had upper respiratory tract symptoms, low-grade fever, and protracted cough; blood oxygen saturation was low and respiratory distress had rapidly increased. An NPA showed HRV-C (FJ435299). He received systemic corticosteroids and was discharged with corticosteroid inhalation. Comparison between 2 HRV-A strains isolated showed 82.5% nucleotide sequence identity. The sequence of the HRV-C strain also displayed 51.2% and 61.1% nucleotide identity to FJ435274 and FJ435284, respectively. Results of phylogenetic analysis are shown in the Figure.
A novel HRV-C infection in association with acute lower RTI was diagnosed in the first patient during her fourth and fifth hospitalizations. The 2 strains isolated are within the same genetic group and display 70% nucleotide similarity, which suggests that this infant was infected with 2 different virus strains. The second patient was infected with HRV-A during his first hospitalization. His condition subsequently progressed to refractory wheezing. Both patients were co-infected with RSV when a diagnosis of infection with lower RTIs was made. Two HRV-A strains detected in the second patient were within the same subgroup, but similarity in nucleotide sequences was only 82.5%. This result suggests that this patient was infected with 2 different virus strains of HRV-A and a strain of HRV-C.
Comparison of the HRV-A strains with the HRV-C strain showed that they belonged to different subgroups and had low similarity for nucleotide sequences. The second patient had 3 distinct rhinovirus infections over 3 months, and each was associated with illness requiring hospitalization. Both patients had underlying diseases, reactive airway diseases, and repeated episodes of RTI that may have rendered them vulnerable to reinfection, compromising their immune responses.
Complete coding sequences of HRV-A and HRV-C have been determined (4,7). However, little is known about their involvement in the pathogenesis of recurrent wheezing in young children. According to recent reports, HRV-C has been detected in hospitalized children with lower RTI in the People’s Republic of China (5). Possible association of novel infection with HRV and exacerbation of asthma in children has also been reported (6). We report HRV-A and HRV-C co-infections in conjunction with other respiratory viruses, such as RSV, as a potential cause of recurrent wheezing in infants with acute lower RTIs. Co-infections with HRV-A and HRV-C may contribute to increased virulence and subsequent pathogenesis of other respiratory viruses. Additional studies will be required to further explore the clinical role of novel HRVs.
We thank P. Hirsch for reviewing the manuscript.
This study was supported by the Higher Commission of Education, Ministry of Education, Thailand, and The Center of Excellence Research Fund, Chulalongkorn University.
- Jennings LC, Anderson TP, Werno AM, Beynon KA, Murdoch DR. Viral etiology of acute respiratory tract infections in children presenting to hospital: role of PCR. Pediatr Infect Dis J. 2004;23:1003–7.
- Briese T, Renwick N, Venter M, Jarman R, Ghosh D, Köndgen S, Global distribution of novel rhinovirus genotype. Emerg Infect Dis. 2008;14:944–7.
- McErlean P, Shackelton L, Lambert S, Nissen M, Sloots T, Mackay I. Characterization of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis. J Clin Virol. 2007;39:67–75.
- Lau SK, Yip CC, Tsoi HW, Lee RA, So LY, Lau YL, Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol. 2007;45:3655–64.
- Xiang Z, Gonzalez R, Xie Z, Xiao Y, Chen L, Li Y, Human rhinovirus group C infection in children with lower respiratory tract infection. Emerg Infect Dis. 2008;14:1665–7.
- Khetsuriani N, Lu X, Gerald Teague W, Kazerouni N, Anderson L, Erdman D. Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis. 2008;14:1793–6.
- McErlean P, Shackelton LA, Andrews E, Webster DR, Lambert SB, Nissen MD, Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C). PLoS ONE. 2008; 3:e1847.
- Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178:667–72.
- Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol. 2005;116:267–73.
- Korppi M, Kotaniemi-Syrjanen A, Waris M, Vainionpää R, Reijonen T. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 2004;23:995–9.
Suggested citation for this article: Linsuwanon P, Payungporn S, Samransamruajkit R, Theamboonlers A, Poovorawan Y. Recurrent human rhinovirus infections in infants with refractory wheezing [letter]. Emerg Infect Dis [serial on the Internet]. 2009 Jun [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/6/08-1558
Comments to the Authors
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: December 08, 2010
- Page last updated: December 08, 2010
- Page last reviewed: December 08, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)